NCT02749968View on ClinicalTrials.gov

Intercostal Liposomal Bupivacaine for the Management of Blunt Chest Wall Trauma

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 9, 2018

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2021

Conditions
Blunt Chest Wall TraumaRib FractureSternal Fracture
Interventions
DRUG

Liposomal bupivacaine

1 mL of liposomal bupivacaine injected with a 25-G needle just below each affected rib by the intercostal neurovascular bundle in a paraspinal position

DRUG

0.9% sodium chloride

1 mL of 0.9% saline injected with a 25-G needle just below each affected rib by the intercostal neurovascular bundle in a paraspinal position

Trial Locations (1)

45216

University of Cincinnati Medical Center, Cincinnati

All Listed Sponsors
collaborator

United States Air Force

FED

lead

University of Cincinnati

OTHER

NCT02749968 - Intercostal Liposomal Bupivacaine for the Management of Blunt Chest Wall Trauma | Biotech Hunter | Biotech Hunter